ID

16057

Descrizione

Documentation part: Log Status & Randomisation Number A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline

Keywords

versioni (1)
  1. 27/06/16 27/06/16 -
Caricato su

27 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

Inglese

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 moduli  
Log Status
Descrizione

Log Status

Did the subject experience any adverse events during the study?
Descrizione

Did the subject experience any adverse events during the study?

Tipo di dati

text

Alias
UMLS CUI [1]
C0877248
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Descrizione

Were any concomitant medications taken by the subject prior to screening and/or during the study?

Tipo di dati

text

Alias
UMLS CUI [1]
C2347852
Case book ready for signature
Descrizione

CRA should check the box when data cleaning is complete. This item is used for Phase I trials only. Remove for Phase II-IV

Tipo di dati

text

Alias
UMLS CUI [1]
C1519316
For inform only: Do not data enter
Descrizione

For inform only: Do not data enter

Q1
Descrizione

Q1

Tipo di dati

text

Q2
Descrizione

Q2

Tipo di dati

text

Randomisation Number (RAND)
Descrizione

Randomisation Number (RAND)

Randomisation number
Descrizione

Randomisation number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0449788
UMLS CUI [1,2]
C0034656
Ritorna all'inizio della pagina

Similar models

Log Status & Randomisation Number Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Log Status
Item
Did the subject experience any adverse events during the study?
text
C0877248 (UMLS CUI [1])
Did the subject experience any adverse events during the study?
Code List
Did the subject experience any adverse events during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
text
C2347852 (UMLS CUI [1])
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Code List
Were any concomitant medications taken by the subject prior to screening and/or during the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
Case book ready for signature
text
C1519316 (UMLS CUI [1])
Case book ready for signature
Code List
Case book ready for signature
CL Item
Yes (Y)
Item Group
For inform only: Do not data enter
Item
Q1
text
Q1
Code List
Q1
CL Item
Yes (Y)
CL Item
No (N)
Item
Q2
text
Q2
Code List
Q2
CL Item
PF_SC_LOST (1)
CL Item
PF_SC_DEATH (2)
CL Item
PF_SC_SPONSORDECISlON (3)
CL Item
PF_SC_PHYS[ClANDEClSlON (4)
CL Item
PF_SC_PATIENTDEClSION (5)
CL Item
PF_SC_AE (6)
CL Item
PF_SC_CRlTERIA (7)
CL Item
PF_SC_OTHER (8)
Item Group
Randomisation Number (RAND)
Randomisation number
Item
Randomisation number
integer
C0449788 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial